RxDoctor Payments Data

Jennifer Weber, DO

Family Medicine · Beaumont, TXNPI 1043656952

Payments from drug & device makers

$12,365in general payments, 2019–2025

Across 824 payments — averaging $15.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Novo Nordisk$2K
  • GSK$863
  • Takeda Pharmaceuticals U.S.A., Inc.$779
  • AstraZeneca$756
  • Amgen$716
  • plus $5K from 40 others

What the payments were for

  • Food & beverage$12,338100%
  • Education$270%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$12,365 in reported general payments places this provider in the 90th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$99,941
Medicare patients
548
Services billed
2,361

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide155$210,672
JardianceEmpagliflozin68$68,328
MounjaroTirzepatide48$61,265
EliquisApixaban48$47,648
Synjardy XrEmpagliflozin/Metformin Hcl35$36,072
Trelegy ElliptaFluticasone/Umeclidin/Vilanter37$32,162
FarxigaDapagliflozin Propanediol32$29,325
Tresiba Flextouch U-200Insulin Degludec20$22,669
JanuviaSitagliptin Phosphate23$20,831
MyrbetriqMirabegron30$20,206
TrulicityDulaglutide13$19,083
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$11,460
Repatha SureclickEvolocumab19$11,165
Repatha SyringeEvolocumab19$9,938
HorizantGabapentin Enacarbil12$6,228

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,981$210,672155 claims
Boehringer IngelheimJardiance, Synjardy Xr$564$104,400103 claims
Lilly USA, LLCMounjaro, Trulicity$590$80,34861 claims
PfizerEliquis, Prempro, Premarin$585$53,17471 claims
GSKTrelegy Ellipta, Anoro Ellipta$863$43,62254 claims
AstraZenecaFarxiga$756$29,32532 claims
MerckJanuvia$373$20,83123 claims
Astellas Pharma US IncMyrbetriq$53$20,20630 claims
Arbor Pharmaceuticals, Inc.Horizant$77$6,22812 claims
AbbVieSynthroid$2,558$2,52465 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Beaumont

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →